Literature DB >> 15533378

Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion.

Toshiaki Endo1, Yoshimitsu Kitajima, Takuhiro Hayashi, Miho Fujii, Hiroshi Hata, Atsushi Azumaguchi.   

Abstract

The most severe complication of ovarian hyperstimulation syndrome (OHSS) is thromboembolism, which is related to hemoconcentration. Dextran 40 infusion has greater effectiveness for the treatment of hemoconcentration due to OHSS than does human albumin infusion.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15533378     DOI： 10.1016/j.fertnstert.2004.04.045

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  3 in total

1.  Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study.

Authors:  Tetsuji Minami; Hayato Yamana; Mph Ph D; Daisuke Shigemi; Hiroki Matsui Mph; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Int J Reprod Biomed       Date:  2019-11-07

Review 2.  Volume expanders for the prevention of ovarian hyperstimulation syndrome.

Authors:  Mohamed A Youssef; Selma Mourad
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31

3.  A new effective method in the treatment of severe ovarian hyperstimulation syndrome.

Authors:  Qingrui Zhang; Liangbin Xia; Gao Gao
Journal:  Iran J Reprod Med       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.